Global Contraceptives Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 - 2025

  • ID: 4394931
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Actavis, Inc.
  • Bayer HealthCare AG
  • CooperSurgical, Inc.
  • Mayer Laboratories, Inc.
  • Merck & Co., Inc.
  • Other Notable Players
  • MORE
Contraceptives Market Growth, Future Prospects and Competitive Analysis, 2017 -2025, the global contraceptives market was valued at USD 21.11 Bn in 2017, and is expected to reach USD 26.79 Bn by 2025, expanding at a CAGR of 3.6% from 2017 - 2025.

Market Insights

Contraception is defined as voluntary method of preventing pregnancy by altering fertilization, ovulation and intervention through drugs and devices. This report studies the current status and future prospects of the drugs and devices commercially available in the global contraceptives market. Temporary contraceptives are the most preferred contraception mode across the world. Some of the prime factors that drive the global contraceptives market are drive to avoid unintentional pregnancies and overcoming the risk of sexually transmitted infections. Growing awareness about productive health, and increased approvals for novel and highly effective female contraceptive solutions also drive the contraceptives market. Initiatives by governments and NGOs to promote the use of contraceptives and public concessions for the same are facilitating to growing demand for contraceptives.

Oral contraceptive pills is the largest product segment in the contraceptives market. Combined hormonal contraceptives are in high demand in the present market scenario, due to their high effectiveness and ease of use. Among the device types, intrauterine devices hold the largest market share demonstrating significant usage in developed markets and growing adoption in emerging markets of Asia-Pacific. Subdermal implants and female condoms have developed their niche in the developed regions of North America and Europe and their awareness is steadily increasing in Latin America and Asian markets.

North America is the largest market for contraceptives followed by Europe. High incidence of teenage and unintentional pregnancy and wide prevalence of sexually transmitted diseases are the major contributors to the dominance of these regions. On the other hand, novel contraceptive solutions such as implants, vaginal rings and others are in high demand in developed countries due to high disposable incomes and high awareness. Asia-Pacific is the most promising regional market for contraceptive drugs and devices. Government and NGO initiatives focusing on population control, prevention of unintentional pregnancies and sexually transmitted diseases in low income groups are responsible for the surge in demand for contraceptives in Asia-Pacific.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Actavis, Inc.
  • Bayer HealthCare AG
  • CooperSurgical, Inc.
  • Mayer Laboratories, Inc.
  • Merck & Co., Inc.
  • Other Notable Players
  • MORE
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 Contraceptives Market Share, by Drugs, 2015 (Value %)
2.2 Contraceptives Market, by Devices, 2015 (USD Mn)
2.3 Contraceptives Market Share, by Geography, 2015 (Value %)

Chapter 3 Contraceptives Market: Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.2 Drivers
3.3 Challenges
3.4 Future Prospects
3.5 Attractive Investment Proposition
3.1 Competitive Analysis: Market Positioning, by Key Market Players

Chapter 4 Global Contraceptives Market Analysis, by Drugs, 2015-2025 (USD Mn)
4.1 Preface
4.2 Contraceptive Pills
4.3 Injectable Contraceptives
4.4 Topical Contraceptives

Chapter 5 Global Contraceptives Market Analysis, by Devices, 2015-2025 (USD Mn)
5.1 Preface
5.2 Male Condoms
5.3 Female Condoms
5.4 Diaphragms
5.5 Contraceptive Sponges
5.6 Vaginal Rings
5.7 Subdermnal Implants
5.8 Intrauterine Devices

Chapter 6 Global Contraceptives Market, by Geography, 2015-2025 (USD Mn)
6.1 Preface
6.2 North America
6.2.1 U.S.
6.2.2 Canada
6.3 Europe
6.3.1 U.K.
6.3.2 Germany
6.3.3 Rest of Europe
6.4 Asia-Pacific
6.4.1 Japan
6.4.2 China
6.4.3 Rest of Asia-Pacific
6.5 Middle East and Africa (MEA)
6.6 Latin America

Chapter 7 Company Profiles
7.1 Teva Pharmaceutical Industries Limited
7.1.1 Business Description
7.1.2 Financial Health and Budget Allocation
7.1.3 Product Positions/Portfolio
7.1.4 News Coverage
7.2 Bayer HealthCare AG
7.2.1 Business Description
7.2.2 Financial Health and Budget Allocation
7.2.3 Product Positions/Portfolio
7.2.4 News Coverage
7.3 Actavis, Inc.
7.3.1 Business Description
7.3.2 Financial Health and Budget Allocation
7.3.3 Product Positions/Portfolio
7.3.4 News Coverage
7.4 Merck & Co., Inc.
7.4.1 Business Description
7.4.2 Financial Health and Budget Allocation
7.4.3 Product Positions/Portfolio
7.4.4 News Coverage
7.5 Church & Dwight, Co., Inc.
7.5.1 Business Description
7.5.2 Financial Health and Budget Allocation
7.5.3 Product Positions/Portfolio
7.5.4 News Coverage
7.6 CooperSurgical, Inc.
7.6.1 Business Description
7.6.2 Financial Health and Budget Allocation
7.6.3 Product Positions/Portfolio
7.6.4 News Coverage
7.7 Reckitt Benckiser plc
7.7.1 Business Description
7.7.2 Financial Health and Budget Allocation
7.7.3 Product Positions/Portfolio
7.7.4 News Coverage
7.8 The Female Health Company
7.8.1 Business Description
7.8.2 Financial Health and Budget Allocation
7.8.3 Product Positions/Portfolio
7.8.4 News Coverage
7.9 Mayer Laboratories, Inc.
7.9.1 Business Description
7.9.2 Financial Health and Budget Allocation
7.9.3 Product Positions/Portfolio
7.9.4 News Coverage
7.10 Other Notable Players

List of Figures
Fig. 1 Contraceptives: Market Segmentation
Fig. 2 Contraceptives Market Share, by Drugs, 2015 (Value %)
Fig. 3 Contraceptives Market, by Devices, 2015 (USD Mn)
Fig. 4 Contraceptives Market Share, by Geography, 2015 (Value %)
Fig. 5 Attractive Investment Proposition, Contraceptives Market, 2015
Fig. 6 Competitive Analysis: Market Positioning, by Key Market Players
Fig. 7 Global Contraceptive Pills Market, 2015 - 2025 (USD Mn)
Fig. 8 Global Injectable Contraceptives Market, 2015 - 2025 (USD Mn)
Fig. 9 Global Topical Contraceptives Market, 2015 - 2025 (USD Mn)
Fig. 10 Global Male Condoms Market, 2015 - 2025 (USD Mn)
Fig. 11 Global Female Condoms Market, 2015 - 2025 (USD Mn)
Fig. 12 Global Diaphragms Market, 2015 - 2025 (USD Mn)
Fig. 13 Global Contraceptive Sponges Market, 2015 - 2025 (USD Mn)
Fig. 14 Global Vaginal Rings Market, 2015 - 2025 (USD Mn)
Fig. 15 Global Subdermnal Implants Market, 2015 - 2025 (USD Mn)
Fig. 16 Global Intrauterine Devices Market, 2015 - 2025 (USD Mn)

List of Tables
Table 1 Global Contraceptives Market, by Drugs, 2015 - 2025 (USD Mn)
Table 2 Global Contraceptives Market, by Devices, 2015 - 2025 (USD Mn)
Table 3 Global Contraceptives Market, by Geography, 2015 - 2025 (USD Mn)
Table 4 North America Contraceptives Market, by Country, 2015 - 2025 (USD Mn)
Table 5 U.S. Contraceptives Market, by Drugs and Devices, 2015 - 2025 (USD Mn)
Table 6 Canada Contraceptives Market, by Drugs and Devices, 2015 - 2025 (USD Mn)
Table 7 Europe Contraceptives Market, by Country, 2015 - 2025 (USD Mn)
Table 8 U.K. Contraceptives Market, by Drugs and Devices, 2015 - 2025 (USD Mn)
Table 9 Germany Contraceptives Market, by Drugs and Devices, 2015 - 2025 (USD Mn)
Table 10 Rest of Europe Contraceptives Market, by Drugs and Devices, 2015 - 2025 (USD Mn)
Table 11 Asia-Pacific Contraceptives Market, by Country, 2015 - 2025 (USD Mn)
Table 12 Japan Contraceptives Market, by Drugs and Devices, 2015 - 2025 (USD Mn)
Table 13 China Contraceptives Market, by Drugs and Devices, 2015 - 2025 (USD Mn)
Table 14 Rest of Asia-Pacific Contraceptives Market, by Drugs and Devices, 2015 - 2025 (USD Mn)
Table 15 Middle East and Africa Contraceptives Market, by Drugs and Devices, 2014 - 2022 (USD Mn)
Table 16 Latin America Contraceptives Market, by Drugs and Devices, 2014 - 2022 (USD Mn)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Teva Pharmaceutical Industries Limited
  • Bayer HealthCare AG
  • Actavis, Inc.
  • Merck & Co., Inc.
  • Church & Dwight, Co., Inc.
  • CooperSurgical, Inc.
  • Reckitt Benckiser plc
  • The Female Health Company
  • Mayer Laboratories, Inc.
  • Other Notable Players
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll